Literature DB >> 21413563

GEMA 2009 (Spanish guideline on the management of asthma).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21413563

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  9 in total

1.  Changes in exhaled nitric oxide levels after bronchial allergen challenge.

Authors:  María Pedrosa; Pilar Barranco; Valentín López-Carrasco; Santiago Quirce
Journal:  Lung       Date:  2012-01-07       Impact factor: 2.584

2.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 3.  Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.

Authors:  Abir Al Said; Breda Cushen; Richard W Costello
Journal:  Ther Adv Chronic Dis       Date:  2017-02-01       Impact factor: 5.091

Review 4.  Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.

Authors:  Gang Wang; Xin Zhang; Hong Ping Zhang; Lei Wang; De Ying Kang; Peter J Barnes; Gang Wang
Journal:  Respir Res       Date:  2017-12-06

Review 5.  Asthma referrals: a key component of asthma management that needs to be addressed.

Authors:  David Price; Leif Bjermer; David A Bergin; Rafael Martinez
Journal:  J Asthma Allergy       Date:  2017-07-25

6.  FENOMA Study: Achieving Full Control in Patients with Severe Allergic Asthma.

Authors:  Sheila Cabrejos; Ana Moreira; Andreina Ramirez; Santiago Quirce; Gregorio Soto Campos; Ignacio Dávila; Paloma Campo
Journal:  J Asthma Allergy       Date:  2020-05-06

7.  Sensitization profile in patients with respiratory allergic diseases: differences between conventional and molecular diagnosis (a cross-sectional study).

Authors:  Guillermo Til-Pérez; Claudio Carnevale; Pedro Luis Sarría-Echegaray; Diego Arancibia-Tagle; Sendy Chugo-Gordillo; Manuel David Tomás-Barberán
Journal:  Clin Mol Allergy       Date:  2019-05-02

8.  Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.

Authors:  José Fernando Florido-López; Carmen Andreu-Balaguer; Carmelo Escudero; Marta Seoane-Rodríguez; Mercedes Hernández; Luis Ángel Navarro-Seisdedos; Miguel Torrecillas-Toro; Mónica Anton-Girones; Leticia Herrero-Lifona; Dorimar Brugaletta; Jesús Macías; Rafael Pineda; Maria Ángeles Lara; Julián López-Caballero; Maria José Rojas
Journal:  World Allergy Organ J       Date:  2020-12-18       Impact factor: 4.084

9.  Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis.

Authors:  Arancha Hevia; Christian Milani; Patricia López; Carmen D Donado; Adriana Cuervo; Sonia González; Ana Suárez; Francesca Turroni; Miguel Gueimonde; Marco Ventura; Borja Sánchez; Abelardo Margolles
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.